Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Covance Web-Based Trial Data System Aims To Cut Time To "Clean" Data

Executive Summary

Covance's web-based clinical trial data collection software licensed from Phase Forward is expected to cut the time required to "clean" clinical trial data for analysis to a week or less, the company said.

You may also be interested in...



Covance Clinical Trials Business Impaired By Mergers, National Politics - CEO

Covance's late-stage clinical trials business has been negatively impacted by the slew of industry mergers and the country's uncertain political climate, CEO Chris Kuebler remarked during the company's third quarter earnings conference call.

Covance Clinical Trials Business Impaired By Mergers, National Politics - CEO

Covance's late-stage clinical trials business has been negatively impacted by the slew of industry mergers and the country's uncertain political climate, CEO Chris Kuebler remarked during the company's third quarter earnings conference call.

Covance Tissue Sample Stockpile Is Possible Asset For Genomics Research

Covance sees its stockpile of tissue samples from past clinical trials as a potential asset for building a genomics testing business in the future, the clinical research organization indicated during its second quarter earnings conference call July 26.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS034627

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel